Cargando…
Mapping lung squamous cell carcinoma pathogenesis through in vitro and in vivo models
Lung cancer is the main cause of cancer death worldwide, with lung squamous cell carcinoma (LUSC) being the second most frequent subtype. Preclinical LUSC models recapitulating human disease pathogenesis are key for the development of early intervention approaches and improved therapies. Here, we re...
Autores principales: | Gómez-López, Sandra, Whiteman, Zoe E., Janes, Sam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342622/ https://www.ncbi.nlm.nih.gov/pubmed/34354223 http://dx.doi.org/10.1038/s42003-021-02470-x |
Ejemplares similares
-
Modeling tuberculosis pathogenesis through ex vivo lung tissue infection
por: Carranza-Rosales, Pilar, et al.
Publicado: (2017) -
Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth
por: Succony, Laura, et al.
Publicado: (2022) -
In vitro monocyte maturation in squamous carcinoma of the lung.
por: Dent, R. G., et al.
Publicado: (1981) -
Pterostilbene inhibits lung squamous cell carcinoma growth in vitro and in vivo by inducing S phase arrest and apoptosis
por: Tan, Kok-Tong, et al.
Publicado: (2019) -
Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
por: Ji, Yubin, et al.
Publicado: (2019)